SM
ALT icon

SG3 Management’s Altimmune ALT Stock Holding History

SG3 Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,700
Closed -$456K – 15
2022
Q4 		$456K Buy
27,700
+4,400
+19% +$49.4K 0.07% 121
2022
Q3 		$298K Buy
+23,300
New +$344K 0.04% 176
2021
Q4 		– Sell
-78,400
Closed -$887K – 1020
2021
Q3 		$887K Buy
+78,400
New +$953K 0.03% 487
2021
Q2 		– Sell
-10,100
Closed -$143K – 997
2021
Q1 		$143K Buy
+10,100
New +$163K ﹤0.01% 1013

Other funds holding ALT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

SG3 Management's ALT Position: Q3 2021 in Review

SG3 Management sold out of Altimmune (ALT) in Q3 2021, closing a stake of 3,000 shares — an estimated $36.5K sold.

SG3 Management first reported a position in ALT in Q1 2021 and held it in 2 quarters. The position peaked at $35K in Q1 2021. 118 funds tracked by Wall St. Rank hold ALT as of Q3 2021.

  • SG3 Management reported no remaining Altimmune position as of Q3 2021 after selling out during the quarter.
  • SG3 Management sold 3,000 Altimmune shares in Q3 2021, an estimated $36.5K.
  • SG3 Management first reported a position in Altimmune in Q1 2021 and held it in 2 quarters.
  • SG3 Management's Altimmune position peaked at $35K in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Altimmune as of Q3 2021.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.